Some experts have argued that patients should routinely be told the specific magnitude and absolute probability of potential risks and benefits of screening tests. This position is motivated by the idea that framing risk information in ways that are less precise violates the ethical principle of respect for autonomy and its application in informed consent or shared decisionmaking. In this Perspective, we consider a number of problems with this view that have not been adequately addressed. The most important challenges stem from the danger that patients will misunderstand the information or have irrational responses to it. Any initia...
Few diseases have raised as many ethical questions as AIDS and HIV infection. One of these question...
Many healthcare practices expose people to risks of harmful outcomes. However, the major theories of...
Advances in data science allow for sophisticated analysis of increasingly large data sets. In the me...
Some experts have argued that patients should routinely be told the specific magnitude and...
Some experts have argued that patients should routinely be told the specific magnitude and absolute ...
Patients should not always receive hard data about the risks and benefits of a medical intervention....
Personal genomic screening, especially when marketed direct-to-consumers, threatens to worsen the in...
Providing individuals with the information necessary to make informed decisions is now considered an...
November 2009 ’ s announcement of the USPSTF ’ s recommendations for screening for breast cancer rai...
The current doctrine of informed consent falls far short of its potential to serve as a valuable saf...
November 2009’s announcement of the USPSTF’s recommendations for screening for breast cancer raised ...
Purpose: The authors analyzed online consumer health information related to screening tests to see h...
With the growing focus on prevention in medicine, studies of how to describe risk have become increa...
In this paper, we illustrate some serious difficulties involved in conveying information about uncer...
BACKGROUND: Providing comprehensive information about the risks and benefits of cancer screening is ...
Few diseases have raised as many ethical questions as AIDS and HIV infection. One of these question...
Many healthcare practices expose people to risks of harmful outcomes. However, the major theories of...
Advances in data science allow for sophisticated analysis of increasingly large data sets. In the me...
Some experts have argued that patients should routinely be told the specific magnitude and...
Some experts have argued that patients should routinely be told the specific magnitude and absolute ...
Patients should not always receive hard data about the risks and benefits of a medical intervention....
Personal genomic screening, especially when marketed direct-to-consumers, threatens to worsen the in...
Providing individuals with the information necessary to make informed decisions is now considered an...
November 2009 ’ s announcement of the USPSTF ’ s recommendations for screening for breast cancer rai...
The current doctrine of informed consent falls far short of its potential to serve as a valuable saf...
November 2009’s announcement of the USPSTF’s recommendations for screening for breast cancer raised ...
Purpose: The authors analyzed online consumer health information related to screening tests to see h...
With the growing focus on prevention in medicine, studies of how to describe risk have become increa...
In this paper, we illustrate some serious difficulties involved in conveying information about uncer...
BACKGROUND: Providing comprehensive information about the risks and benefits of cancer screening is ...
Few diseases have raised as many ethical questions as AIDS and HIV infection. One of these question...
Many healthcare practices expose people to risks of harmful outcomes. However, the major theories of...
Advances in data science allow for sophisticated analysis of increasingly large data sets. In the me...